![5H-Cyclopenta[d]pyrazolo[1,5-a]pyrimidine-2-carboxamide, 6,7-dihydro-N-(5-methyl-1,3,4-thiadiazol-2-yl)-8-(trifluoromethyl)- (9CI) structure](/static/products/606/606096-56-4.png)
5H-Cyclopenta[d]pyrazolo[1,5-a]pyrimidine-2-carboxamide, 6,7-dihydro-N-(5-methyl-1,3,4-thiadiazol-2-yl)-8-(trifluoromethyl)- (9CI)
概要：5H-Cyclopenta[d]pyrazolo[1,5-a]pyrimidine-2-carboxamide, 6,7-dihydro-N-(5-methyl-1,3,4-thiadiazol-2-yl)-8-(trifluoromethyl)- (9CI)（CAS 606096-56-4）是一种化学化合物，分子式为C14H11F3N6OS，分子量为368.07 g/mol。河南科弘生物科技有限公司提供CRO/CDMO定制合成服务，支持克级到吨级规格。
N-(5-methyl-1,3,4-thiadiazol-2-yl)-2-(trifluoromethyl)-1,8,12-triazatricyclo[7.3.0.03,7]dodeca-2,7,9,11-tetraene-11-carboxamide
又称：5H-Cyclopenta[d]pyrazolo[1,5-a]pyrimidine-2-carboxamide, 6,7-dihydro-N-(5-methyl-1,3,4-thiadiazol-2-yl)-8-(trifluoromethyl)- (9CI)
| 分子式 | C14H11F3N6OS |
|---|---|
| 分子量 | 368.07 g/mol |
| LogP | 2.64902 |
| 拓扑极性表面积 | 85.07 Ų |
| 氢键供体数 | 1 |
| 氢键受体数 | 6 |
| 可旋转键数 | 2 |
| 精确质量 | 368.0667 |
| 重原子数 | 25 |
| 复杂度 | 992.5172 |
化学标识符
| CAS 编号 | 606096-56-4 |
|---|---|
| SMILES | CC1=NN=C(S1)NC(=O)C2=NN3C(=C2)N=C4CCCC4=C3C(F)(F)F |
产品概述
5H-Cyclopenta[d]pyrazolo[1,5-a]pyrimidine-2-carboxamide, 6,7-dihydro-N-(5-methyl-1,3,4-thiadiazol-2-yl)-8-(trifluoromethyl)- (9CI)（CAS 606096-56-4），分子式为C14H11F3N6OS，分子量为368.07 g/mol。IUPAC名：N-(5-methyl-1,3,4-thiadiazol-2-yl)-2-(trifluoromethyl)-1,8,12-triazatricyclo[7.3.0.03,7]dodeca-2,7,9,11-tetraene-11-carboxamide。
5H-Cyclopenta[d]pyrazolo[1,5-a]pyrimidine-2-carboxamide, 6,7-dihydro-N-(5-methyl-1,3,4-thiadiazol-2-yl)-8-(trifluoromethyl)- (9CI)化学性质概览
属性洞察：5H-Cyclopenta[d]pyrazolo[1,5-a]pyrimidine-2-carboxamide, 6,7-dihydro-N-(5-methyl-1,3,4-thiadiazol-2-yl)-8-(trifluoromethyl)- (9CI)
5H-Cyclopenta[d]pyrazolo[1,5-a]pyrimidine-2-carboxamide, 6,7-dihydro-N-(5-methyl-1,3,4-thiadiazol-2-yl)-8-(trifluoromethyl)- (9CI)的XLogP值为2.64902，表明具有中等亲脂性，在水溶性和膜透过性之间取得平衡。 TPSA为85.07 Ų，处于中等极性范围，在透过性和溶解性之间取得平衡。 根据Lipinski五规则，5H-Cyclopenta[d]pyrazolo[1,5-a]pyrimidine-2-carboxamide, 6,7-dihydro-N-(5-methyl-1,3,4-thiadiazol-2-yl)-8-(trifluoromethyl)- (9CI)有1个氢键供体和6个氢键受体，均在类药范围内，提示具有较好的口服生物利用度潜力。
常见问题
常见问题
5H-Cyclopenta[d]pyrazolo[1,5-a]pyrimidine-2-carboxamide, 6,7-dihydro-N-(5-methyl-1,3,4-thiadiazol-2-yl)-8-(trifluoromethyl)- (9CI)的CAS号是多少？
5H-Cyclopenta[d]pyrazolo[1,5-a]pyrimidine-2-carboxamide, 6,7-dihydro-N-(5-methyl-1,3,4-thiadiazol-2-yl)-8-(trifluoromethyl)- (9CI)的CAS号为606096-56-4。
5H-Cyclopenta[d]pyrazolo[1,5-a]pyrimidine-2-carboxamide, 6,7-dihydro-N-(5-methyl-1,3,4-thiadiazol-2-yl)-8-(trifluoromethyl)- (9CI)的分子式是什么？
5H-Cyclopenta[d]pyrazolo[1,5-a]pyrimidine-2-carboxamide, 6,7-dihydro-N-(5-methyl-1,3,4-thiadiazol-2-yl)-8-(trifluoromethyl)- (9CI)的分子式为C14H11F3N6OS。
5H-Cyclopenta[d]pyrazolo[1,5-a]pyrimidine-2-carboxamide, 6,7-dihydro-N-(5-methyl-1,3,4-thiadiazol-2-yl)-8-(trifluoromethyl)- (9CI)的分子量是多少？
5H-Cyclopenta[d]pyrazolo[1,5-a]pyrimidine-2-carboxamide, 6,7-dihydro-N-(5-methyl-1,3,4-thiadiazol-2-yl)-8-(trifluoromethyl)- (9CI)的分子量为368.07 g/mol。
在哪里可以购买5H-Cyclopenta[d]pyrazolo[1,5-a]pyrimidine-2-carboxamide, 6,7-dihydro-N-(5-methyl-1,3,4-thiadiazol-2-yl)-8-(trifluoromethyl)- (9CI)？
您可以直接向科弘生物询价5H-Cyclopenta[d]pyrazolo[1,5-a]pyrimidine-2-carboxamide, 6,7-dihydro-N-(5-methyl-1,3,4-thiadiazol-2-yl)-8-(trifluoromethyl)- (9CI)。联系我们或发送邮件至info@kehongbio.com获取报价和库存信息。
科弘生物是否提供5H-Cyclopenta[d]pyrazolo[1,5-a]pyrimidine-2-carboxamide, 6,7-dihydro-N-(5-methyl-1,3,4-thiadiazol-2-yl)-8-(trifluoromethyl)- (9CI)的定制合成服务？
是的，科弘生物提供5H-Cyclopenta[d]pyrazolo[1,5-a]pyrimidine-2-carboxamide, 6,7-dihydro-N-(5-methyl-1,3,4-thiadiazol-2-yl)-8-(trifluoromethyl)- (9CI)及相关化合物的定制合成服务。请联系我们并告知您的具体需求，包括数量、纯度和交期。